September 2017

Convening Experts to Examine the Critical Underpinnings of Antimicrobial Resistance Strategies

Scenarios of a post-antibiotic society are dire and include massive, highly preventable loss of life, widening socio-economic disparities, and significant economic shortfalls. Estimates of the potential economic impact of antimicrobial resistance (AMR) could be as large as a global annual GDP shortfall of nearly $3.4 trillion by 2030 and $7 trillion by 2050.[i] Currently, 700,000 people die every year due to drug-resistant infections globally.[ii]

Share

Introducing the USP Quality Institute

Amid the backdrop of the 72nd United Nations General Assembly (UNGA), USP introduced its Quality Institute – a center that will conduct much-needed research to foster evidence-based policy decisions that can help increase the availability of quality-assured medicines worldwide.

Share

A Center of Excellence to Secure Medicines Quality Through the Supply Chain

USP and the Asia Pacific Economic Cooperation (APEC) partners are exploring new ways to stem the tide of substandard and falsified medicines. Read more.

Share